ArticleNature communications2025

Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.

Zhan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.